| OXYMETAZOLINE HYDROCHLORIDE | RVL PHARMS | ||
| 0.1% ; SOLUTION/DROPS |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| UPNEEQ is indicated for the treatment of acquired blepharoptosis in adults. | |||
|
Yes
| |||
| UPNEEQ | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||
| ************ *** ******* *** ***-******** ********* ** ****** | ************ *** ******* *** ***-******** ********* ** ****** | ************ *** ******* *** ***-******** ********* ** ****** | ************ *** ******* *** ******** ****** ********* | ************* ************ | ************* ************ | ************ *** ******* *** ******** ****** ********* | ************* ************ | ************* ************ | ************ *** ******* *** ******** ****** ********* | ************* ************ | ************ *** ******* *** ******** ****** ********* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|